About The Study: This study of buprenorphine and methadone supplies to treat opioid use disorder during the COVID-19 pandemic found a pronounced decline in the methadone supply but no disruption to the buprenorphine supply.
Authors: Bradley D. Stein, M.D., Ph.D., of the RAND Corporation in Pittsburgh, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.23708)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.23708?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072622
JAMA Network Open